Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Latest news and developments in the Macmillan Support and Information Service
-
Information about staff who work in the Macmillan Support and Information Service.
-
Bones marrow harvest patient information page.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
File results
-
FOI/2023/0475 - Agency usage for the decontamination department
-
FOI/2023/0476 - Single longest wait in A&E for mental health related issue
-
FOI/2023/0478 - Social media management platform
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI/2023/0485 - Heart attacks 2019/22
-
FOI/2023/0487 - Maintenance of corporate estate
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0493 - Treatments for various diseases